Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients.

Follicular lymphoma shows a wide geographic variation in incidence, occurring more frequently in the U.S. than in Japan. A translocation involving the bcl-2 gene on chromosome 18 and the immunoglobulin heavy chain gene on chromosome 14 is frequently found in follicular lymphomas and is believed to play a critical role in the pathogenesis of these tumors. Recently, bcl-2/IgH rearrangements have been detected in reactive lymphoid tissue obtained from European patients, indicating that such rearrangements occur at some low but measurable background rate. In non-malignant tissues, the polymerase chain reaction was used to study the frequency of bcl-2/IgH rearrangements in reactive lymphoid tissue obtained from American and Japanese patients to find out whether geographic variation in the incidence of follicular lymphoma was caused by differences in sporadic occurrence of the t(14;18). We found such rearrangements in 5 of 15 American hyperplastic tonsils and lymph nodes and 5 of 10 Japanese tonsils, an incidence close to that previously seen in European patients. These data suggest that the background incidence of such rearrangements is similar in all populations, regardless of the incidence of follicular lymphoma.

[1]  John Calvin Reed,et al.  Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease. , 1991, The American journal of pathology.

[2]  S. Korsmeyer,et al.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Lister,et al.  Detection of additional JH/BCL2 translocations in follicular lymphoma. , 1991, Leukemia.

[4]  E. Zucca,et al.  Direct sequence analysis of 14q+ and 18q- chromosome junctions at the MBR and MCR revealing clustering within the MBR in follicular lymphoma. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  G. Pinkus,et al.  Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Southern blot analysis and polymerase chain reaction. , 1991, The American journal of pathology.

[6]  T. McDonnell,et al.  Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.

[7]  B. Johansson,et al.  Geographic heterogeneity of neoplasia‐associated chromosome aberrations , 1991, Genes, chromosomes & cancer.

[8]  M. Seto,et al.  bcl‐2 Translocation in Japanese B Cell Lyraphoma: Novel bcl‐2 Translocation with Immunoglobulin Heavy Chain Diversity Segment , 1991, Japanese journal of cancer research : Gann.

[9]  R. Schreiber,et al.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.

[10]  T. Chan,et al.  Rearrangement of immunoglobulin, T‐cell receptor, and bcl‐2 genes in malignant lymphomas in Hong Kong , 1990, Cancer.

[11]  M. Raffeld,et al.  Translocation of bcl‐2 gene in non‐Hodgkin's lymphomas in Hong Kong Chinese , 1990, British journal of haematology.

[12]  E. Zucca,et al.  Direct sequence analysis of the 14q+ and 18q- chromosome junctions in follicular lymphoma. , 1990, Blood.

[13]  M. Stetler-Stevenson,et al.  Involvement of the bcl-2 gene in Hodgkin's disease. , 1990, Journal of the National Cancer Institute.

[14]  P. Nowell,et al.  BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Korsmeyer,et al.  Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. , 1990, Journal of immunology.

[16]  S. Fukuhara,et al.  [bcl-2 gene involved in Japanese follicular lymphoma]. , 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[17]  G. Sarkar,et al.  Shedding light on PCR contamination , 1990, Nature.

[18]  K. Aozasa,et al.  Non-Hodgkin's lymphomas of follicular center cell type in Osaka, Japan. , 1989, European journal of cancer & clinical oncology.

[19]  M. Seto,et al.  bcl‐2 Gene Rearrangement Analysis in Japanese B Cell Lymphoma; Novel bcl‐2 Recombination with Immimoglobulin K Chain Gene , 1989, Japanese journal of cancer research : Gann.

[20]  S. Korsmeyer,et al.  Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Lukes,et al.  Malignant lymphoma in Hawaii‐Japanese: A retrospective morphologic survey , 1989, Hematological oncology.

[22]  S. Korsmeyer,et al.  bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.

[23]  S. Tanabe,et al.  Involvement of bcl-2 gene in Japanese follicular lymphoma. , 1989, Blood.

[24]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[25]  R. Warnke,et al.  Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. , 1988, The New England journal of medicine.

[26]  P. Nowell,et al.  Pre-B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma. , 1988, Oncogene.

[27]  R. Warnke,et al.  Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. , 1987, The New England journal of medicine.

[28]  D. Weisenburger,et al.  Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study. , 1987, Human pathology.

[29]  M. Oken,et al.  Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. , 1987, The New England journal of medicine.

[30]  N. Harris Lymphoma 1987. An interim approach to diagnosis and classification. , 1987, Pathology annual.

[31]  Correlation of Chromosome Abnormalities With Histologic and Immunologic Characteristics in Non-Hodgkin ’ s Lymphoma and Adult , 2022 .

[32]  J. Sklar,et al.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.

[33]  R. Hoover,et al.  Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. , 1986, JAMA.

[34]  L. Shih,et al.  Pathologic and immunologic characterization of malignant lymphoma in Taiwan. With special reference to retrovirus-associated adult T-cell lymphoma/leukemia. , 1985, American journal of clinical pathology.

[35]  J. Sklar,et al.  Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Croce,et al.  The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. , 1985, Science.

[37]  S. Korsmeyer,et al.  Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18 , 1985, Cell.

[38]  Y. Tsujimoto,et al.  Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.

[39]  A retrospective histological study of 9,009 cases of malignant lymphoma in China using the NLPCG classification. The Nationwide Lymphoma Pathology Cooperative Group (NLPCG). , 1985, Japanese Journal of Clinical Oncology.

[40]  D. Todd,et al.  Clinico‐pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight‐year period , 1984, International journal of cancer.

[41]  C. Berard,et al.  Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States--Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. , 1983, Human pathology.

[42]  K. Lennert,et al.  Concordance of the Kiel and Lukes‐Collins classifications of non‐Hodgkin's lymphomas , 1983, Histopathology.

[43]  J. Rowley,et al.  Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. , 1979, Cancer research.